Showing results (361-370 of 449) with videos related to
Sort By:
Pageof 45
British Journal of Cancer|October 11, 2012
Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcomeA Schramm, B Schowe, K Fielitz, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
High ALK receptor tyrosine kinase expression supersedes ALK mutation as a determining factor of an unfavorable phenotype in primary neuroblastomaJohannes H Schulte, Hagen S Bachmann, Bent Brockmeyer, et al.Klinische Padiatrie|June 1, 2017
2017 GPOH Guidelines for Diagnosis and Treatment of Patients with Neuroblastic TumorsThorsten Simon, Barbara Hero, Johannes H Schulte, et al.International Journal of Cancer|December 7, 2020
Inhibiting phosphoglycerate dehydrogenase counteracts chemotherapeutic efficacy against MYCN-amplified neuroblastomaBirte Arlt, Christin Zasada, Katharina Baum, et al.Nucleic Acids Research|April 30, 2013
MYCN and HDAC2 cooperate to repress miR-183 signaling in neuroblastomaMarco Lodrini, Ina Oehme, Christina Schroeder, et al.Iscience|December 5, 2024
Copy-number dosage regulates telomere maintenance and disease-associated pathways in neuroblastomaMartin Burkert, Eric Blanc, Nina Thiessen, et al.Oncotarget|October 22, 2016
Characterization of pancreatic glucagon-producing tumors and pituitary gland tumors in transgenic mice overexpressing MYCN in hGFAP-positive cellsKathrin Fielitz, Kristina Althoff, Katleen De Preter, et al.Genome Biology|October 5, 2012
Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkersAnneleen Decock, Maté Ongenaert, Jasmien Hoebeeck, et al.Journal of Synchrotron Radiation|July 3, 2015
The Extreme Conditions Beamline P02.2 and the Extreme Conditions Science Infrastructure at PETRA IIIH P Liermann, Z Konôpková, W Morgenroth, et al.Journal of Clinical Medicine|October 26, 2024
Targeting KDM1A in Neuroblastoma with NCL-1 Induces a Less Aggressive Phenotype and Suppresses AngiogenesisAnnika Sprüssel, Takayoshi Suzuki, Naoki Miyata, et al.Pageof 45